2005•PubMedRequires access
Course of joint disease in patients with antinuclear antibody-positive juvenile idiopathic arthritis.
Enrico Felici, Cristina Novarini, Silvia Magni‐Manzoni, Angela Pistorio, Alessandra Magnani, Elena Bozzola, Antonella Buoncompagni, Alberto Martini, Angelo Ravelli
Open publisher page 53 citations
Abstract
OBJECTIVE: To describe the patterns and time course of arthritis in patients with antinuclear antibody (ANA)-positive juvenile idiopathic arthritis (JIA). METHODS: We identified patients followed during a 16-year period who had JIA by ILAR criteria, were ANA-positive (i.e., had >or= 2 positive ANA test results at titer >or= 1:160), and had a disease duration >or= 2 years. Demographic and clinical features, including ILAR category and cumulative number and type of joints affected over time, were recorded. RESULTS: A total of 195 patients were studied. The ILAR category was oligoarthritis in 159 patients and rheumatoid factor-negative polyarthritis in 36 patients. The cumulative rate of polyarticular extension in patients with oligoarticular onset was 26%, 38%, 45%, 49%, and 51% at 1, 2, 3, 4, and 5 years, respectively. At disease onset, most patients had monoarthritis and 95% had